Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PET practice in nuclear pharmacy.

Ronald C Walker1, Steven S Zigler

  • 1University of Arkansas for Medical Sciences, Little Rock, Ark., USA.

Journal of the American Pharmacists Association : Japha
|November 25, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

FDA Investigator Training for PET Drug Manufacturing Inspections.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025
Same author

Proceedings: PET Drugs-A 2023 Workshop on Product Quality, Regulatory Submissions, Facility Inspections, and Benefit-Risk Considerations.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025
Same author

Reply to "Foregoing Nonclinical Dosimetry Studies to Support First-in-Human Studies of Certain PET Radiopharmaceuticals".

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025
Same author

FDA Reconsiders Rules Around Radiation Dosimetry for First-in-Human Studies of Investigational PET Radiopharmaceuticals.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025
Same author

18F-FSPG PET imaging for the evaluation of indeterminate pulmonary nodules.

PloS one·2022
Same author

Proceedings: PET Drugs-A Workshop on Inspections Management and Regulatory Considerations.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2022
Same journal

Healthcare cost savings through hospital pharmacist-collaborative care in heart failure: A microsimulation study.

Journal of the American Pharmacists Association : JAPhA·2026
Same journal

Assessment of comprehensive medication management incorporating a patient-completed medical and medication history form in community practice.

Journal of the American Pharmacists Association : JAPhA·2026
Same journal

Characterizing how community pharmacy teams engage with social drivers of health (SDOH) during routine workflow: A report from the medication safety research network of Indiana (Rx-SafeNet).

Journal of the American Pharmacists Association : JAPhA·2026
Same journal

Geographic disparities in board-certified ambulatory care pharmacists in Appalachia.

Journal of the American Pharmacists Association : JAPhA·2026
Same journal

Development of consensus criteria for problematic medications in active duty service members.

Journal of the American Pharmacists Association : JAPhA·2026
Same journal

Barriers and facilitators to pharmacy-based methadone dosing and dispensing: Semi-structured interviews with pharmacists.

Journal of the American Pharmacists Association : JAPhA·2026
See all related articles

Positron Emission Tomography (PET) imaging reveals biochemical processes in normal and diseased states. Advances in PET and CT scanner technology enhance clinical utility for visualizing cancer cells using [18F]fluorodeoxyglucose (FDG).

Area of Science:

  • Physics
  • Biochemistry
  • Medical Imaging

Background:

  • Positron Emission Tomography (PET) systems offer unique insights into normal and disease biochemical processes.
  • Fluorodeoxyglucose (FDG) is crucial in PET chemistry for visualizing glucose uptake in cancer cells.
  • External imaging techniques cannot match the detailed biochemical process visualization provided by PET.

Framework:

  • The production of sterile, injectable [18F]fluorodeoxyglucose (FDG) involves a complex series of steps for [18F]fluoride ion production.
  • PET and Computed Tomography (CT) scanner development is enhancing the clinical utility of both imaging modalities.

Implementation:

  • The core of PET imaging relies on understanding theoretical and practical physics principles.
  • FDG's role as a radiotracer highlights the intersection of chemistry and nuclear medicine.

Related Experiment Videos

  • The manufacturing process for FDG requires meticulous control over radioisotope production and formulation.

    • Implications:

    • Advancements in PET and CT scanner technology promise to significantly improve diagnostic capabilities.
    • Enhanced visualization of metabolic processes aids in early disease detection and treatment monitoring.
    • The integration of PET and CT provides more comprehensive anatomical and functional information for patient care.